Liquid chromatographic determination of a new catechol-O-methyltransferase inhibitor, entacapone, and its Z-isomer in human plasma and urine

This publication has 10 references indexed in Scilit:

• Reduction of Circulating 3-O-Methyldopa by Inhibition of Gatechol-O-Methyltransferase With OR-611 and OR-462 in Cynomolgus Monkeys
  Clinical Neuropharmacology, 1991
• Determination of a catechol-O-methyltransferase inhibitor, nitecapone, in human plasma and urine by liquid chromatography
  Journal of Pharmaceutical and Biomedical Analysis, 1991
• Rationale for Selective COMT Inhibitors as Adjuncts in the Drug Treatment of Parkinson's Disease
  Basic & Clinical Pharmacology & Toxicology, 1990
• Neural mechanisms of dystonia: Evidence from a 2‐deoxyglucose uptake study in a primate model of dopamine agonist‐induced dystonia
  Movement Disorders, 1990
• Reactivity Considerations in the Analysis of Glucuronide and Sulfate Conjugates of Diflunisal
  Therapeutic Drug Monitoring, 1989
• New selective COMT inhibitors: useful adjuncts for Parkinson's disease?
  Trends in Pharmacological Sciences, 1989
• Clinical Pharmacokinetics of Anti-Parkinsonian Drugs
  Clinical Pharmacokinetics, 1987
• The pharmacokinetics of intravenous and oral levodopa in patients with Parkinson's disease who exhibit on‐off fluctuations.
  British Journal of Clinical Pharmacology, 1986
• Pharmacokinetics of Levodopa
  Clinical Neuropharmacology, 1984
• Measurement of phenol in urine using a high-performance liquid chromatographic method
  The Analyst, 1984